Compliance Investigations & White Collar

6 Rivkin Radler Partners to Present at USLAW Virtual Retreat
September 21, 2020 | Corporate | Intellectual Property | General Liability | Employment & Labor | Directors & Officers Liability | Commercial Litigation | Bankruptcy | Appeals | Compliance Investigations & White Collar | Real Estate, Zoning & Land Use | Professional Liability
Uniondale, New York – September 2020 – Six attorneys from Rivkin Radler will be speakers at USLAW Network’s virtual retreat, which takes place September 30 through October 9. The retreat is intended for general counsel, in-house counsel, heads and managers of claims and risk, C-suite executives, and other legal decision makers. The program will cover …
Read More
Bank, Bholan and Kaiser Secure Pre-answer Dismissal
September 17, 2020 | Compliance Investigations & White Collar
Brian Bank, Michelle Bholan, and Geoffrey Kaiser secured pre-answer dismissal of various False Claims Act claims brought against three New York nephrologists by a relator, also a nephrologist. The action, which the relator brought on behalf of the United States of America under the False Claims Act’s qui tam provisions, alleged two theories against the …
Read More
Kaiser Quoted in Part B News
August 27, 2020 | Compliance Investigations & White Collar
Jeff Kaiser was quoted in Part B News, “Do Stark waivers cover your rent break? Only if the break meets ‘COVID-19 purposes.” The article discusses the new Stark Law waivers issued due to the COVID-19 pandemic. One waiver in particular covers rental arrangements that are under fair market value (FMV) which are normally forbidden under …
Read More
Ullman Quoted on FDA Import Alert Request
August 4, 2020 | Compliance Investigations & White Collar
Marc Ullman was interviewed for the Natural Products Insider article, “FDA, supplement manufacturer debate NDI import alert request.” The article discusses why the FDA should issue an import alert on beta-alanine ingredients manufactured in China. To read the full article, click here. …
Read More
Ullman to Present at Virtual Hemp-CBD Supplement Congress
July 20, 2020 | Cannabis | Health Services | Compliance Investigations & White Collar
On August 27, Marc Ullman will be presenting at the American Herbal Products Association (AHPA) Hemp-CBD Supplement Virtual Congress. The seminar will provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. Click here to register. …
Read More
Rivkin Health Attorneys Write the Book on Federal AKS and Safe Harbors
July 9, 2020 | Health Services | Compliance Investigations & White Collar
Eric Fader, Jeff Kaiser, Chris Kutner, Ada Kozicz and Ben Malerba are authors of the newly released book, “The Federal Anti-Kickback Statute and Safe Harbors: A Practical Guide.” Published by the American Bar Association, the book covers all safe harbors currently in place, as well as the interplay between the Anti-Kickback Statute (AKS) and other …
Read More
Ullman Participates in Q&A on COVID-19 and the Natural Products Industry
July 2, 2020 | Compliance Investigations & White Collar
Marc Ullman spoke with Vitamin Retailer about the repercussions of the Coronavirus pandemic on the natural products industry. He was joined by 11 other panelists representing manufacturers, industry associations and consultants to the industry. To read the Q&A click here. …
Read More
Ullman Lends Perspective on FDA Warning Letter
June 4, 2020 | Cannabis | Compliance Investigations & White Collar
Marc Ullman was quoted in a article entitled “Warning letter cites CBD’s regulatory status as leading issue.” The Food and Drug Administration sent a warning letter to a supplement manufacturer regarding various failures in good manufacturing practice (GMP). For the first time, however, the letter cited the health claims made about CBD as the first …
Read More
Ullman Lends Perspective on Import Alerts for Dietary Supplements
June 3, 2020 | Compliance Investigations & White Collar
Marc Ullman was quoted in the article, “NPA calls for FDA to issue import alerts on imported adulterated dietary supplement ingredients.” The Natural Products Association is requesting that the Food and Drug Administration deal with the import of nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations. Marc noted that FDA has …
Read More
Iseman Quoted in Part B News on Medical Practices’ Reopening
May 18, 2020 | Compliance Investigations & White Collar | Health Services | Commercial Litigation
Robert Iseman spoke to Part B News about how medical practices should take steps to protect themselves from legal and insurance issues. The article, “Assess legal risk, payer policies to head off hidden dangers of COVID-19 reopening,” advises medical practices that are beginning to reopen on preparations they can make to be ready for any …
Read More
Next Page

Get legal updates and news delivered to your inbox